XRAY - DENTSPLY SIRONA Inc Stock Price, Fair Value and News

27.76USD-0.49 (-1.73%)Delayed as of 08 May 2024, 01:23 pm ET

Market Summary

USD27.76-0.49

Delayedas of 08 May 2024, 01:23 pm

-1.73%

XRAY Alerts

Big jump in Earnings (Y/Y)

XRAY Stock Price

View Fullscreen

XRAY RSI Chart

XRAY Valuation

Market Cap

5.9B

Price/Earnings (Trailing)

-62.76

Price/Sales (Trailing)

1.49

EV/EBITDA

76.29

Price/Free Cashflow

13.87

XRAY Price/Sales (Trailing)

XRAY Profitability

EBT Margin

-2.94%

Return on Equity

-2.87%

Return on Assets

-1.31%

Free Cashflow Yield

7.21%

XRAY Fundamentals

XRAY Revenue

Revenue (TTM)

3.9B

Rev. Growth (Yr)

-2.56%

Rev. Growth (Qtr)

-5.83%

XRAY Earnings

Earnings (TTM)

-93.5M

Earnings Growth (Yr)

178.26%

Earnings Growth (Qtr)

-74.1%

Breaking Down XRAY Revenue

52 Week Range

27.6841.65

(Low)(High)

Last 7 days

-5.8%

Last 30 days

-12.5%

Last 90 days

-16.2%

Trailing 12 Months

-31.6%

How does XRAY drawdown profile look like?

XRAY Financial Health

Current Ratio

1.43

Debt/Equity

0.54

Debt/Cashflow

0.24

XRAY Investor Care

Dividend Yield

2.05%

Dividend/Share (TTM)

0.58

Buy Backs (1Y)

2.28%

Diluted EPS (TTM)

-0.44

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	3.9B	0	0	0
2023	3.9B	3.9B	3.9B	4.0B
2022	4.2B	4.1B	4.0B	3.9B
2021	3.5B	4.0B	4.2B	4.2B
2020	4.0B	3.5B	3.4B	3.3B
2019	4.0B	3.9B	4.0B	4.0B
2018	4.0B	4.1B	4.0B	4.0B
2017	3.9B	3.8B	3.9B	4.0B
2016	2.8B	3.1B	3.4B	3.7B
2015	2.8B	2.8B	2.7B	2.7B
2014	2.9B	3.0B	3.0B	2.9B
2013	2.9B	2.9B	3.0B	3.0B
2012	2.7B	2.8B	2.9B	2.9B
2011	2.2B	2.3B	2.4B	2.5B
2010	2.2B	2.2B	2.2B	2.2B
2009	2.1B	2.1B	2.1B	2.2B
2008	0	2.1B	2.1B	2.2B
2007	0	0	0	2.0B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of DENTSPLY SIRONA Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 12, 2024	johnson robert anthony	acquired	-	-	354	svp, chief supply chain office
Apr 12, 2024	lucier gregory t	acquired	-	-	26.426	-
Apr 12, 2024	frank andreas g	acquired	-	-	503	exec vp/chief business officer
Apr 12, 2024	mazelsky jonathan jay	acquired	-	-	26.426	-
Apr 12, 2024	campion simon d	acquired	-	-	1,088	president, ceo & member of bod
Apr 12, 2024	brandt eric	acquired	-	-	72.546	-
Apr 12, 2024	rosenzweig richard c	acquired	-	-	215	svp, corp dev, gc & secretary
Apr 12, 2024	coleman glenn	acquired	-	-	302	executive vp & cfo
Apr 12, 2024	wagner richard m	acquired	-	-	41.653	vp, chief accounting officer
Apr 12, 2024	holden betsy d	acquired	-	-	129	-

Which funds bought or sold XRAY recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 06, 2024	Savant Capital, LLC	reduced	-3.42	-126,130	1,143,310	0.01%
May 06, 2024	Hardman Johnston Global Advisors LLC	added	8.14	186,989	22,352,400	0.77%
May 06, 2024	DUALITY ADVISERS, LP	new	-	1,166,330	1,166,330	0.12%
May 06, 2024	Envestnet Portfolio Solutions, Inc.	added	6.56	-2,253	356,716	-%
May 06, 2024	Jefferies Financial Group Inc.	sold off	-100	-2,045,090	-	-%
May 06, 2024	TEACHER RETIREMENT SYSTEM OF TEXAS	added	28.24	342,000	2,087,000	0.01%
May 06, 2024	JOHN G ULLMAN & ASSOCIATES INC	added	31.69	1,053,260	5,670,350	0.87%
May 06, 2024	Quantbot Technologies LP	added	121	1,321,550	2,563,930	0.14%
May 06, 2024	SG Americas Securities, LLC	added	2,959	43,986,000	45,584,000	0.22%
May 06, 2024	Sciencast Management LP	sold off	-100	-575,882	-	-%

Are Funds Buying or Selling XRAY?

Are funds buying XRAY calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own XRAY

No. of Funds

XRAY Alerts

Big jump in Earnings (Y/Y)

Unveiling DENTSPLY SIRONA Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	11.89%	25,187,041	SC 13G/A
Feb 12, 2024	artisan partners limited partnership	6.1%	12,944,034	SC 13G/A
Feb 05, 2024	nuance investments, llc	5.48%	11,603,889	SC 13G/A
Jan 29, 2024	blackrock inc.	6.2%	13,136,945	SC 13G/A
Feb 13, 2023	generation investment management llp	2.21%	4,747,746	SC 13G/A
Feb 10, 2023	artisan partners limited partnership	6.3%	13,582,284	SC 13G/A
Feb 09, 2023	vanguard group inc	11.69%	25,121,756	SC 13G/A
Feb 08, 2023	nuance investments, llc	5.88%	12,642,319	SC 13G
Feb 03, 2023	blackrock inc.	7.9%	16,978,584	SC 13G/A
Mar 09, 2022	blackrock inc.	10.9%	23,745,567	SC 13G/A

Recent SEC filings of DENTSPLY SIRONA Inc

View All Filings

Date Filed	Form Type	Document
May 02, 2024	10-Q	Quarterly Report
May 02, 2024	8-K	Current Report
Apr 15, 2024	4	Insider Trading
Apr 15, 2024	4	Insider Trading
Apr 15, 2024	4	Insider Trading
Apr 15, 2024	4	Insider Trading
Apr 15, 2024	4	Insider Trading
Apr 15, 2024	4	Insider Trading
Apr 15, 2024	4	Insider Trading
Apr 15, 2024	4	Insider Trading

Peers (Alternatives to DENTSPLY SIRONA Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	184.5B	40.3B	-4.60%	-4.35%	32.81	4.58	-2.84%	-3.08%
BDX	68.5B	19.7B	-3.65%	-5.69%	51.42	3.48	4.82%	-17.56%
ALGN	21.6B	3.9B	-9.77%	-6.38%	46.66	5.51	5.72%	46.72%
BAX	18.4B	14.9B	-15.25%	-20.81%	6.95	1.24	2.98%	207.68%
MID-CAP
ATR	9.9B	3.5B	5.58%	23.16%	31.71	2.8	6.16%	35.06%
HSIC	9.1B	12.5B	-1.81%	-10.76%	23.5	0.73	-0.61%	-18.83%
BIO	8.2B	2.7B	-13.87%	-26.12%	-12.81	3.06	-4.68%	82.43%
XRAY	5.9B	3.9B	-12.53%	-31.61%	-62.76	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	-0.62%	22.51%	-215.76	8.88	30.82%	65.57%
PDCO	2.3B	6.6B	-0.84%	-0.80%	12.05	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	-6.97%	-19.30%	-1.87	0.4	7.94%	-1661.78%
ANIK	420.5M	166.7M	10.85%	9.31%	-5.09	2.52	6.67%	-456.34%
ANGO	245.9M	324.0M	-12.80%	-31.58%	-1.28	0.76	-3.19%	-337.41%
APYX	48.8M	52.3M	-6.00%	-59.48%	-2.61	0.93	17.61%	19.28%
AEMD	3.4M	3.7M	-25.71%	271.43%	-0.27	0.89	5.77%	8.23%

DENTSPLY SIRONA Inc News

Latest updates

DENTSPLY SIRONA Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-5.8%	953	1,012	947	1,028	978	983	947	1,023	969	1,103	1,040	1,062	1,026	1,076	883	499	881	1,112	962	1,009	946
Gross Profit	-3.1%	506	522	495	550	519	517	508	581	521	604	569	595	579	567	432	182	475	611	514	541	500
S&GA Expenses	1.5%	415	409	372	416	416	402	401	410	376	377	395	393	386	373	313	259	357	325	399	431	432
R&D Expenses	-2.3%	42.00	43.00	46.00	49.00	46.00	43.00	41.00	45.00	45.00	49.00	39.00	43.00	40.00	38.00	29.00	20.00	36.00	-	-	-	-
EBITDA Margin	154.2%	0.02*	0.01*	0.00*	-0.26*	-0.25*	-0.22*	-0.18*	0.15*	0.16*	0.17*	0.17*	0.16*	0.12*	-	-	-	-	-	-	-	-
Interest Expenses	-21.7%	18.00	23.00	18.00	21.00	19.00	24.00	14.00	15.00	12.00	18.00	14.00	15.00	14.00	14.00	14.00	11.00	7.00	7.00	7.00	8.00	8.00
Income Taxes	193.3%	14.00	-15.00	16.00	-39.00	-5.00	23.00	-164	18.00	18.00	37.00	29.00	35.00	33.00	24.00	9.00	-22.00	12.00	35.00	22.00	11.00	15.00
Earnings Before Taxes	-45.6%	31.00	57.00	-250	46.00	-28.00	8.00	-1,241	91.00	87.00	156	113	131	145	129	57.00	-114	-122	130	107	48.00	54.00
EBT Margin	33.3%	-0.03*	-0.04*	-0.06*	-0.31*	-0.30*	-0.27*	-0.22*	0.11*	0.12*	0.13*	0.12*	0.11*	0.06*	-	-	-	-	-	-	-	-
Net Income	-74.1%	18.00	70.00	-266	85.00	-23.00	-15.00	-1,077	73.00	69.00	119	84.00	96.00	112	105	47.00	-91.00	-134	102	85.00	36.00	39.00
Net Income Margin	30.0%	-0.02*	-0.03*	-0.06*	-0.26*	-0.27*	-0.24*	-0.20*	0.08*	0.09*	0.10*	0.09*	0.09*	0.05*	-	-	-	-	-	-	-	-
Free Cashflow	-84.4%	25.00	160	134	104	-58.25	105	109	173	-	187	-	-	27.00	242	176	144	-40.75	269	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-3.4%	7,123	7,370	7,201	7,650	7,673	7,643	7,522	8,948	9,172	9,239	9,289	9,378	9,137	9,350	8,896	8,604	8,058	8,603	8,367	8,575	8,605
Current Assets	-3.6%	1,902	1,973	1,913	1,920	1,943	1,893	1,939	1,885	1,897	1,852	1,805	1,785	1,696	1,798	2,580	2,363	1,805	2,000	1,811	1,828	1,796
Cash Equivalents	-12.9%	291	334	309	295	318	365	418	362	374	339	281	332	318	438	1,272	1,109	236	405	226	250	225
Inventory	-1.8%	613	624	651	657	659	627	592	581	553	515	548	539	1.00	476	489	549	591	562	605	608	618
Net PPE	-2.2%	782	800	753	772	770	761	714	744	771	773	771	769	758	791	772	772	777	802	783	820	854
Goodwill	-1.6%	2,400	2,438	2,374	2,703	2,701	2,688	2,584	3,858	3,944	3,976	4,000	4,033	3,952	3,986	3,283	3,227	3,192	3,397	3,356	3,413	3,399
Liabilities	-5.2%	3,865	4,076	3,830	3,948	4,035	3,831	3,908	4,110	4,308	4,242	4,226	4,301	4,207	4,415	4,134	3,959	3,368	3,508	3,308	3,392	3,495
Current Liabilities	-6.7%	1,330	1,425	1,218	1,271	1,374	1,170	1,296	1,241	1,372	1,261	1,199	1,251	1,212	1,372	1,178	763	892	995	869	881	871
Long Term Debt	-2.7%	1,747	1,796	1,803	1,841	1,842	1,826	1,737	1,807	1,872	1,913	1,925	1,946	1,923	1,978	1,930	2,183	1,421	1,433	1,404	1,441	1,545
LT Debt, Non Current	-100.0%	-	1,796	1,803	1,841	1,842	1,826	1,737	1,807	1,872	1,913	1,925	1,946	1,923	1,978	1,930	2,183	1,421	1,433	1,404	1,441	1,545
Shareholder's Equity	-1.1%	3,258	3,293	3,375	3,702	3,638	3,811	3,614	4,838	4,864	4,997	5,063	5,034	4,890	4,935	4,720	4,608	4,649	5,048	5,059	5,183	5,110
Retained Earnings	-7.3%	190	205	167	463	407	456	498	1,602	1,556	1,514	1,419	1,402	1,328	1,198	1,156	1,125	1,242	1,404	1,324	1,262	1,245
Additional Paid-In Capital	-0.1%	6,639	6,643	6,645	6,648	6,604	6,629	6,619	6,617	6,573	6,606	6,659	6,638	6,618	6,604	6,592	6,577	6,554	6,587	6,567	6,551	6,520
Shares Outstanding	0.2%	208	207	212	212	213	215	216	216	217	217	219	219	219	-	-	-	-	-	-	-	-
Minority Interest	-100.0%	-	1.00	-4.00	-4.00	-3.00	1.00	1.00	1.00	1.00	1.00	3.00	3.00	3.00	3.00	2.00	2.00	3.00	2.00	2.00	2.00	2.00
Float	-	-	-	-	8,463	-	-	-	7,665	-	-	-	13,791	-	-	-	9,606	-	-	-	13,062	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-84.4%	25.00	160	134	104	-21.00	142	109	173	93.00	-	-	-	-	264	221	174	-10.00	306	159	145	29.00
Share Based Compensation	-15.4%	11.00	13.00	2.00	14.00	17.00	12.00	14.00	22.00	11.00	-6.00	22.00	19.00	13.00	11.00	17.00	9.00	10.00	16.00	15.00	25.00	9.00
Cashflow From Investing	-115.0%	-43.00	-20.00	-2.00	-30.00	-37.00	-29.00	-26.00	-40.00	-43.00	-	-	-	-	-1,101	-25.00	36.00	-16.00	-29.30	-15.20	-11.80	-12.70
Cashflow From Financing	89.1%	-14.00	-128	-109	-87.00	17.00	-161	-6.00	-152	-10.00	-	-	-	-53.00	-15.00	-37.00	658	-130	-101	-160	-110	-99.20
Dividend Payments	-100.0%	-	30.00	29.00	30.00	27.00	26.00	27.00	27.00	24.00	24.00	24.00	22.00	22.00	22.00	22.00	22.00	22.00	22.00	20.00	20.00	20.00
Buy Backs	-100.0%	-	150	-	-	150	-	-	-	150	110	-	-	90.00	-	-	-	140	100	100	60.00	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

XRAY Income Statement

2024-03-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net sales	$ 953	$ 978
Cost of products sold	447	459
Gross profit	506	519
Selling, general, and administrative expenses	415	416
Research and development expenses	42	46
Intangible asset impairments	6	0
Restructuring and other costs	1	59
Operating income (loss)	42	(2)
Other income and expenses:
Interest expense, net	18	20
Other (income) expense, net	(7)	6
Income (loss) before income taxes	31	(28)
Provision (benefit) for income taxes	14	(5)
Net income (loss)	17	(23)
Less: Net loss attributable to noncontrolling interest	(1)	(4)
Net income (loss) attributable to Dentsply Sirona	$ 18	$ (19)
Net income (loss) per common share attributable to Dentsply Sirona:
Basic (in dollars per share)	$ 0.09	$ (0.09)
Diluted (in dollars per share)	$ 0.09	$ (0.09)
Weighted average common shares outstanding:
Basic (in shares)	207.4	214.5
Diluted (in shares)	208.5	214.5

XRAY Balance Sheet

2024-03-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 291	$ 334
Accounts and notes receivable-trade, net	656	695
Inventories, net	613	624
Prepaid expenses and other current assets	342	320
Total Current Assets	1,902	1,973
Property, plant, and equipment, net	782	800
Operating lease right-of-use assets, net	171	178
Identifiable intangible assets, net	1,618	1,705
Goodwill	2,400	2,438
Other noncurrent assets	250	276
Total Assets	7,123	7,370
Current Liabilities:
Accounts payable	279	305
Accrued liabilities	681	749
Income taxes payable	27	49
Notes payable and current portion of long-term debt	343	322
Total Current Liabilities	1,330	1,425
Long-term debt	1,747	1,796
Operating lease liabilities	120	125
Deferred income taxes	214	228
Other noncurrent liabilities	454	502
Total Liabilities	3,865	4,076
Commitments and contingencies (Note 14)
Equity:
Preferred stock, $1.00 par value; 0.25 million shares authorized; no shares issued	0	0
Common stock, $0.01 par value; 400.0 million shares authorized, and 264.5 million shares issued at March 31, 2024 and December 31, 2023, 211.8 million and 215.3 million shares outstanding at March 31, 2024 and December 31, 2023	3	3
Capital in excess of par value	6,639	6,643
Retained earnings	190	205
Accumulated other comprehensive loss	(666)	(636)
Treasury stock, at cost, 56.9 million and 57.3 million shares at March 31, 2024 and December 31, 2023, respectively	(2,908)	(2,922)
Total Dentsply Sirona Equity	3,258	3,293
Noncontrolling interests	0	1
Total Equity	3,258	3,294
Total Liabilities and Equity	$ 7,123	$ 7,370

About DENTSPLY SIRONA Inc

DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.

CEO	Mr. Simon D. Campion
WEBSITE	dentsplysirona.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	15000

DENTSPLY SIRONA Inc Frequently Asked Questions

What is the ticker symbol for DENTSPLY SIRONA Inc? What does XRAY stand for in stocks?

XRAY is the stock ticker symbol of DENTSPLY SIRONA Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of DENTSPLY SIRONA Inc (XRAY)?

As of Tue May 07 2024, market cap of DENTSPLY SIRONA Inc is 5.87 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of XRAY stock?

You can check XRAY's fair value in chart for subscribers.

What is the fair value of XRAY stock?

You can check XRAY's fair value in chart for subscribers. The fair value of DENTSPLY SIRONA Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of DENTSPLY SIRONA Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for XRAY so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is DENTSPLY SIRONA Inc a good stock to buy?

The fair value guage provides a quick view whether XRAY is over valued or under valued. Whether DENTSPLY SIRONA Inc is cheap or expensive depends on the assumptions which impact DENTSPLY SIRONA Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for XRAY.

What is DENTSPLY SIRONA Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue May 07 2024, XRAY's PE ratio (Price to Earnings) is -62.76 and Price to Sales (PS) ratio is 1.49. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. XRAY PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on DENTSPLY SIRONA Inc's stock?

In the past 10 years, DENTSPLY SIRONA Inc has provided -0.042 (multiply by 100 for percentage) rate of return.